Allete (ALE)
(Delayed Data from NYSE)
$64.27 USD
+3.43 (5.64%)
Updated May 3, 2024 04:00 PM ET
After-Market: $64.31 +0.04 (0.06%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$64.27 USD
+3.43 (5.64%)
Updated May 3, 2024 04:00 PM ET
After-Market: $64.31 +0.04 (0.06%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth C Momentum B VGM
Zacks News
Reasons to Add Alliant Energy (LNT) to Your Portfolio Now
by Zacks Equity Research
Alliant Energy (LNT) makes a strong case for investment, given its estimate revision history, earnings surprise history and systematic investments to strengthen its infrastructure and serve customers efficiently.
Reasons to Add Pinnacle West Capital (PNW) to Your Portfolio
by Zacks Equity Research
Pinnacle West Capital's (PNW) rising estimates, strong investment plan and expanding customer base, which are increasing service demands, make it a solid option to add to your portfolio.
NRG Energy (NRG) Expands, to Buy Vivint Smart Home for $5.2B
by Zacks Equity Research
NRG Energy (NRG) decides to acquire Vivint Smart Home, further expanding its operation in the Essential Home Services market and diversifying its financial profile.
ALE vs. HE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ALE vs. HE: Which Stock Is the Better Value Option?
Reasons to Add ALLETE (ALE) to Your Portfolio Right Now
by Zacks Equity Research
ALLETE Inc.'s (ALE) rising earnings estimates and a solid investment plan to strengthen its infrastructure make a strong case for adding it to your portfolio.
Allete (ALE) Is Up 2.97% in One Week: What You Should Know
by Zacks Equity Research
Does Allete (ALE) have what it takes to be a top stock pick for momentum investors? Let's find out.
MDU Resources (MDU) 5-Year Capex to Focus on Infrastructure
by Zacks Equity Research
MDU Resources (MDU) announces a five-year capital expenditure plan, which is set to further strengthen the electric & gas delivery and construction materials and services businesses.
ALE or HE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ALE vs. HE: Which Stock Is the Better Value Option?
Allete (ALE) Q3 Earnings Miss Estimates
by Zacks Equity Research
Allete (ALE) delivered earnings and revenue surprises of -15.71% and 7.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
NiSource (NI) Q3 Earnings Miss Estimates
by Zacks Equity Research
NiSource (NI) delivered earnings and revenue surprises of -9.09% and 9.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Dominion Energy (D) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Dominion Energy (D) delivered earnings and revenue surprises of 2.78% and 12.11%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
PSEG (PEG) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
PSEG (PEG) delivered earnings and revenue surprises of 2.38% and 0.59%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include Terns Pharmaceuticals, AllianceBernstein Holding and ALLETE
by Zacks Equity Research
Terns Pharmaceuticals, AllianceBernstein Holding and ALLETE have been highlighted in this Screen of The Week article.
3 Stocks for Higher Returns as New Analysts Initiate Coverage
by Shrabana Mukherjee
Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Terns Pharmaceuticals (TERN), AllianceBernstein (AB) and ALLETE (ALE).
Why Allete (ALE) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allete (ALE) have what it takes? Let's find out.
NRG Energy (NRG) Gains on Diverse Customers & Debt Management
by Zacks Equity Research
NRG Energy (NRG) gains from steady demand from a diverse customer base and contributions from the Direct Energy takeover. However, any unfavorable fluctuation in foreign currency regulations is a woe.
Xcel Energy (XEL) Gains From Investment & Customer Growth
by Zacks Equity Research
Xcel Energy (XEL), with systematic investments, an expanding customer base and emissions reduction, is poised for growth. However, its dependence on subsidiaries and regulations are headwinds.
FirstEnergy (FE) Benefits From Investment & Debt Management
by Zacks Equity Research
FirstEnergy (FE), with consistent investments, proper debt management and an initiative for lowering emissions, is poised for growth. However, unfavorable weather and regulations are headwinds.
Allete (ALE) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Allete (ALE) delivered earnings and revenue surprises of 6.35% and 6.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Ameren (AEE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Ameren (AEE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Allete (ALE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Allete (ALE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ALE vs. EXC: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ALE vs. EXC: Which Stock Is the Better Value Option?
NRG Energy (NRG) Gains on Diverse Customers & Debt Management
by Zacks Equity Research
NRG Energy (NRG) is likely to gain from the steady demand from its diverse customer base and contributions from the Direct Energy acquisition. However, any fluctuation in foreign currency regulations is a headwind.
4 Reasons to Add ALLETE (ALE) to Your Portfolio Right Now
by Zacks Equity Research
ALLETE (ALE) makes a good case for investment in the utility space, given its systematic capital expenditure, growth in earnings estimates and proper management of debts.
Allete (ALE) Q1 Earnings Lag Estimates
by Zacks Equity Research
Allete (ALE) delivered earnings and revenue surprises of -3.88% and 4.68%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?